echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Winbond Health Methylprednisolone Sodium Succinate for Injection passed the consistency evaluation of generic drugs

    Winbond Health Methylprednisolone Sodium Succinate for Injection passed the consistency evaluation of generic drugs

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 9th, Winbond Health announced that Winbond Pharmaceuticals, a wholly-owned subsidiary, has recently received the "Notice of Supplementary Application Approval" for methylprednisolone sodium succinate for chemical injections approved and issued by the National Medical Products Administration.
    The drug passed the consistency evaluation of generic drugs
    .

    Methylprednisolone sodium succinate for injection is a kind of freeze-dried powder of glucocorticoid drugs.
    It has strong anti-inflammatory, anti-allergic, anti-shock, and immunosuppressive effects.
    It is clinically used in acute and critically ill patients.
    Period, and maintenance treatment after first aid
    .


    Mainly used for anti-inflammatory therapy, immunosuppressive therapy, blood disease, tumor, shock therapy, endocrine disorders


    The original manufacturer of methylprednisolone sodium succinate for injection was Pfizer, USA.
    It was first listed in the US in 1959 and was approved for import in China in 1999
    .


    According to the enlarged version of the hospital data (including urban public hospitals, county-level public hospitals, urban community hospitals, and township health centers) on Minai.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.